Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anterix Inc.ATEX · Entity 4597 | Director · President and CEO | August 23, 2024 | August 26, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anterix Inc.
Report date August 23, 2024 · Filed August 26, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 115,867 |
Reported balance
After 2024-08-23 transaction · row 1
1 source rowRow 1 · 2024-08-23 · Tax withholding · Disposed 6,355 · Balance 115,867 F1: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 23, 2024 Filed Aug 26, 2024 20:45 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 6,355 | $37.54 | $238,566.70 |
DisclosureSEC source: 0001304492-24-000110 · wk-form4_1724705096.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,867 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 11:52 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 8,045 | $39.59 | $318,501.55 |
DisclosureSEC source: 0001304492-24-000082 · wk-form4_1720007570.xml · nonDerivative · entry 2 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,222 F2 · shares: The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of the RSU. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 11:52 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 15,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001304492-24-000082 · wk-form4_1720007570.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,267 F1 · shares: On December 31, 2020, the Reporting Person was granted a performance-based restricted stock unit (the "RSU"). The Compensation Committee determined that the performance objectives under the RSU were satisfied, resulting in the vesting of the reported shares of common stock under the RSU. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 00:48 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 127,189 | $0.00 Strike: $36.00 | $0.00 |
DisclosureSEC source: 0001304492-24-000036 · wk-form4_1710290889.xml · derivative · entry 2 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,189 Underlying: Common Stock · 127,189 shares Expires 2034-03-09 F2 · derivative.exercise_date: 1/3 of the option shares vest and become exercisable on May 22, 2025, with the remaining option shares vesting in 2 equal annual installments thereafter. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 00:48 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 21,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001304492-24-000036 · wk-form4_1710290889.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,467 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 1/3 of the RSUs vest on May 22, 2025, with the remaining RSUs vesting in 2 equal annual installments thereafter. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 23:11 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 6,390 | $33.48 | $213,937.20 |
DisclosureSEC source: 0001209191-23-047437 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,939 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 18, 2023 Filed May 22, 2023 22:55 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 2,044 | $31.11 | $63,588.84 |
DisclosureSEC source: 0001209191-23-031596 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,329 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 12:53 UTC | Anterix Inc. ATEX · Entity 4597 | PurchaseCommon Stock | 2,500 | $29.96 | $74,900.00 |
DisclosureSEC source: 0001209191-23-018068 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,373 Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 23:38 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 77,102 | $0.00 Strike: $49.39 | $0.00 |
DisclosureSEC source: 0001209191-22-060107 · doc4.xml · derivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,102 Underlying: Common Stock · 77,102 shares Expires 2032-12-02 F1 · derivative.exercise_date: 25% of the option shares vest and become exercisable on December 2, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 22:41 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 6,394 | $44.20 | $282,614.80 |
DisclosureSEC source: 0001209191-22-047582 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,873 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 01:38 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 2,062 | $42.47 | $87,573.14 |
DisclosureSEC source: 0001209191-22-033342 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,267 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:22 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 122,449 | $0.00 Strike: $49.39 | $0.00 |
DisclosureSEC source: 0001209191-22-030509 · doc4.xml · derivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,449 Underlying: Common Stock · 122,449 shares Expires 2032-05-17 F1 · derivative.exercise_date: 25% of the option shares vest and become exercisable on May 17, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter. Read SEC document |
| September 20, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 1,995 | $57.31 | $114,338.44 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · nonDerivative · entry 14 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,329 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F12 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $57.08 to $57.79. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 20, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 5,727 | $56.59 | $324,097.80 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · nonDerivative · entry 13 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,324 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F11 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $56.05 to $57.02. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 20, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 3,790 | $55.25 | $209,404.32 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · nonDerivative · entry 12 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,051 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F10 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $55.00 to $56.00. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 17, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 16,212 | $0.00 Strike: $24.45 | $0.00 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · derivative · entry 17 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,089 Underlying: Common Stock · 16,212 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: The option shares are fully vested and may be exercised at any time. Read SEC document |
| September 17, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 361 | $58.17 | $21,000.49 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · nonDerivative · entry 11 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,841 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F9 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $58.10 to $58.255. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 17, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 13,391 | $57.38 | $768,409.06 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · nonDerivative · entry 10 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,202 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $57.06 to $58.04. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 17, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 6,472 | $56.47 | $365,481.61 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · nonDerivative · entry 9 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,593 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $56.02 to $57.00. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 17, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 8,530 | $55.35 | $472,110.76 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · nonDerivative · entry 8 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,065 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $55.01 to $56.00. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 17, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 16,212 | $24.45 | $396,383.40 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · nonDerivative · entry 7 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,699 | $0.00 Strike: $24.45 | $0.00 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · derivative · entry 16 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,301 Underlying: Common Stock · 9,699 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: The option shares are fully vested and may be exercised at any time. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,223 | $0.00 Strike: $26.59 | $0.00 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · derivative · entry 15 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,040 Underlying: Common Stock · 13,223 shares Expires 2025-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: The option shares are fully vested and may be exercised at any time. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 6,598 | $57.63 | $380,238.78 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · nonDerivative · entry 6 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,383 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $57.49 to $57.91. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 7,514 | $57.23 | $430,008.94 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · nonDerivative · entry 5 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,981 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $56.485 to $57.485. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 3,415 | $55.90 | $190,907.38 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · nonDerivative · entry 4 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,495 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $55.44 to $56.41. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 5,395 | $54.88 | $296,088.93 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · nonDerivative · entry 3 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,910 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $54.43 to $54.42. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 9,699 | $24.45 | $237,140.55 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · nonDerivative · entry 2 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 23:14 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 13,223 | $26.59 | $351,599.57 |
DisclosureSEC source: 0001209191-21-056954 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,606 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 01:19 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 21,010 | $0.00 Strike: $26.59 | $0.00 |
DisclosureSEC source: 0001209191-21-056304 · doc4.xml · derivative · entry 15 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,263 Underlying: Common Stock · 21,010 shares Expires 2025-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option shares are fully vested and may be exercised at any time. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 01:19 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 271 | $57.36 | $15,543.67 |
DisclosureSEC source: 0001209191-21-056304 · doc4.xml · nonDerivative · entry 12 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,383 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F9 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $57.18 to $57.46. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 01:19 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 12,356 | $56.31 | $695,734.23 |
DisclosureSEC source: 0001209191-21-056304 · doc4.xml · nonDerivative · entry 11 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,654 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $56.10 to $57.01. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 01:19 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 8,383 | $55.68 | $466,737.78 |
DisclosureSEC source: 0001209191-21-056304 · doc4.xml · nonDerivative · entry 10 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,010 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $55.095 to $56.095. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 01:19 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 21,010 | $26.59 | $558,655.90 |
DisclosureSEC source: 0001209191-21-056304 · doc4.xml · nonDerivative · entry 9 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 01:19 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,505 | $0.00 Strike: $26.59 | $0.00 |
DisclosureSEC source: 0001209191-21-056304 · doc4.xml · derivative · entry 14 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,273 Underlying: Common Stock · 10,505 shares Expires 2025-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option shares are fully vested and may be exercised at any time. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 01:19 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 2,052 | $58.63 | $120,298.91 |
DisclosureSEC source: 0001209191-21-056304 · doc4.xml · nonDerivative · entry 8 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,383 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $58.435 to $58.865. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 01:19 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 8,453 | $57.94 | $489,738.08 |
DisclosureSEC source: 0001209191-21-056304 · doc4.xml · nonDerivative · entry 7 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,435 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $57.43 to $58.425. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 01:19 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 10,505 | $26.59 | $279,327.95 |
DisclosureSEC source: 0001209191-21-056304 · doc4.xml · nonDerivative · entry 6 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2021 Filed Sep 16, 2021 01:19 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,222 | $0.00 Strike: $26.59 | $0.00 |
DisclosureSEC source: 0001209191-21-056304 · doc4.xml · derivative · entry 13 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,778 Underlying: Common Stock · 10,222 shares Expires 2025-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option shares are fully vested and may be exercised at any time. Read SEC document |
| September 13, 2021 Filed Sep 16, 2021 01:19 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 118 | $61.25 | $7,227.50 |
DisclosureSEC source: 0001209191-21-056304 · doc4.xml · nonDerivative · entry 5 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,383 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| September 13, 2021 Filed Sep 16, 2021 01:19 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 1,792 | $60.44 | $108,308.12 |
DisclosureSEC source: 0001209191-21-056304 · doc4.xml · nonDerivative · entry 4 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,501 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $60.005 to $60.95. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 13, 2021 Filed Sep 16, 2021 01:19 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 1,192 | $59.23 | $70,605.74 |
DisclosureSEC source: 0001209191-21-056304 · doc4.xml · nonDerivative · entry 3 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,293 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $58.88 to $59.64. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 13, 2021 Filed Sep 16, 2021 01:19 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 7,120 | $58.30 | $415,061.11 |
DisclosureSEC source: 0001209191-21-056304 · doc4.xml · nonDerivative · entry 2 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,485 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $57.86 to $58.83. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 13, 2021 Filed Sep 16, 2021 01:19 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 10,222 | $26.59 | $271,802.98 |
DisclosureSEC source: 0001209191-21-056304 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 22:30 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $57.00 | $0.00 |
DisclosureSEC source: 0001209191-21-053361 · doc4.xml · derivative · entry 2 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-08-23 F2 · derivative.exercise_date: 25% of the option shares vest and become exercisable on August 23, 2022 with the remaining shares vesting in 3 equal annual installments thereafter. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 22:30 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-053361 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,383 F1 · kind: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on August 23, 2022 with the remaining shares vesting in 3 equal annual installments thereafter. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 21:58 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 3,409 | $48.32 | $164,722.88 |
DisclosureSEC source: 0001209191-21-036909 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,383 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 plan in order to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:40 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-007474 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,850 F1 · shares: The performance-based restricted stock units (the "Units") vest upon the Reporting Person's continued service and achievement of certain stock price levels calculated utilizing a four-year compound annual growth rate and based on the average closing bid price per share of the Issuer's common stock measured over a sixty (60) trading-day period. The Reporting Person may vest in a minimum of 25% of the target reported Units and up to a maximum of 350% of the target reported Units based on specified stock price levels. The vesting end measurement date is February 1, 2025, with earlier vesting determination dates upon a change in control of Issuer, the involuntary termination of the Reporting Person or twelve (12) months following the achievement of the maximum stock price level. If after February 1, 2023, the Reporting Person achieves a stock price level, there will be a vesting determination date the earlier of 12 months thereafter or February 1, 2025. Read SEC document |
| December 29, 2020 Filed May 4, 2021 00:52 UTC | Anterix Inc. ATEX · Entity 4597 | GiftCommon Stock | 1,058 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029651 · doc5.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,792 F1 · kind: These transactions represent a charitable contribution by the Reporting Person. Read SEC document |
| September 03, 2020 Filed Sep 3, 2020 22:40 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 6,493 | $42.70 | $277,258.89 |
DisclosureSEC source: 0001209191-20-049552 · doc4.xml · nonDerivative · entry 2 Schwartz Robert Harris · CIK 0001654170 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,850 F2 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted June 2016 and February 2020. F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $42.22 to $42.7034. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.